Head-to-head · WeighScore
Trava Health vs Wisp
The verdict
Trava Health takes it — 68.6/100 to 64.4/100.
Trava Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Houston-based DTC telehealth offering compounded semaglutide+B12 and tirzepatide+B12 through SIX named 503A compounding pharmacy partners disclosed on Trava's own Terms + Telehealth Consent pages…
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Trava Health | Wisp |
|---|---|---|
| WeighScore | 68.6/100 | 64.4/100 |
| Grade | C | C |
| Scorecard rank | #144 | #243 |
| Semaglutide | $119/mo (starting dose, compounded) | $225/mo (compounded oral) |
| Tirzepatide | $198/mo (starting dose, compounded) | Not disclosed |
| Coverage | All 50 states | Coverage not published |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Yes |
Graded #144 · C
Strengths
- Six named compounding pharmacy partners disclosed in 3rd-party reviews
- Independent batch testing by Eagle Analytical (FDA-registered lab)
- Free overnight shipping included
- No membership fee — pay only for medication
- HSA/FSA eligible
Where it loses points
- No LegitScript accreditation badge surfaced
- BBB F rating with 2 unanswered complaints (BBB file opened 2025-07-07)
- Clinician roster page returns 404 — no public team listing
- Founder/CEO not publicly named on site
- Higher dose pricing gated behind questionnaire (not transparent on public page)
Graded #243 · C
Strengths
- Broad GLP-1 menu — branded injectables (Wegovy, Zepbound, Saxenda) plus a compounded sublingual option
- LegitScript certified with named board-certified providers (Dr. Shannon Chatham DO, Andrea Sleeth WHNP-BC)
- Unusually candid about the sublingual option's limits, noting effectiveness in patients may vary
Where it loses points
- The $99/mo tirzepatide figure is a consultation-and-care subscription, not the medication: Zepbound is filled at a pharmacy of your choice at its own cost, which Wisp does not publish
- The compounded semaglutide option is sublingual drops, which Wisp itself describes as less effective than injection
- Brand-name access is a prescription, not a dispensed product, so the drug cost is outside anything quoted here
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.